淋巴瘤中信号通路的蛋白组分析
Björn Häupl1,2,3, Anne Christine Wilke1, Henning Urlaub4,5
1Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany.
Methods in molecular biology (Clifton, N.J.)
|October 18, 2024
概括
这项研究提出了一种质谱法,用于分析细胞信号,识别数千个酸化事件. 这种方法有助于理解癌症机制,并发现新的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 细胞命运是由信号传导控制的,通常涉及蛋白质酸化.
- 淋巴瘤表现出对癌症发展至关重要的信号通路的失调.
- 识别瘤原因驱动因素,比如扩散性大B细胞淋巴瘤中的B细胞抗原受体,是关键.
研究的目的:
- 开发和描述基于质谱的蛋白质基方法.
- 为了使细胞内信号事件及其动态的全球分析.
- 确定癌症中潜在的诊断生物标志物和治疗点.
主要方法:
- 利用基于质谱的蛋白原子工作流.
- 组合的基丰富和分化.
- 使用液体染色学-合质谱仪进行特定地点的分析.
主要成果:
- 实现了细胞内信号事件的全球分析.
- 识别和量化了数千个酸化事件.
- 证明了特定地点的识别和量化潜力.
结论:
- 全球基蛋白质组分析提供了对瘤致癌病理机制的洞察.
- 这种方法可以识别新的诊断生物标志物.
- 该方法对于在癌症治疗中发现新的药物标非常有价值.
更多相关视频
12:23Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
12.1K
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
13.7K
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Amplifying Signals via Enzymatic Cascade
8.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
